抄録
In two patients with primary bone lymphoma (PBL) treated in our clinic, serum levels of soluble interleukin-2 receptor (sIL-2R) reflected the clinical course. In both cases, sIL-2R levels were high before treatment and normalized with the therapeutic effects of chemotherapy, coinciding with the changes in lactate dehydrogenase levels and radiographic findings. Adding to the recently reported results of the diagnostic ability of sIL-2R in PBL, our case study highlights the clinical significance of serum sIL-2R levels as a tumor marker in PBL cases.
| 本文言語 | English |
|---|---|
| ページ（範囲） | 125-131 |
| ページ数 | 7 |
| ジャーナル | Case Reports in Oncology |
| 巻 | 4 |
| 号 | 1 |
| DOI | |
| 出版ステータス | Published - 2011 1月 |
| 外部発表 | はい |
ASJC Scopus subject areas
- 腫瘍学